-
Blog BLOG
-
Product Center BRAND DYNAMICS
-
Investor INVESTOR RELATIONS
-
Contact Us CONTACT
-
Supervise SUPERVISION
Reaffirmed! Health Yuan selected for the "Capital Market 30 Years · Regional Economic Leader" Honor Roll
Published Time:
2020-12-23
Recently, the "Capital Market 30th Anniversary Regional Economic Leader" honor roll, grandly unveiled by the Securities Times and hosted by eCompany, has been released! Joincare Pharmaceutical Group Industry Co., Ltd. (hereinafter referred to as "Health Yuan") and its holding company, Lizhu Pharmaceutical Group Co., Ltd., stood out from the listed companies selected proportionally from 31 provinces, autonomous regions, and municipalities across China (excluding Hong Kong, Macao, and Taiwan), winning the "Capital Market 30th Anniversary Regional Economic Leader" honor roll top 300.

It is understood that the organizer of this selection, the Securities Times, was founded in 1993. It is a national financial and securities daily newspaper supervised and hosted by the People's Daily, and is a designated publication for disclosing listed company information by the China Securities Regulatory Commission, insurance information by the China Insurance Regulatory Commission, and trust company information by the China Banking Regulatory Commission. It has a significant influence in the capital market. According to the organizer, this selection activity is based on a comprehensive data score, expert review score, and online voting, with a final score calculated as 5:3:2. The "Capital Market 30th Anniversary Regional Economic Leader" honor roll was selected based on the proportion of listed companies in each provincial administrative region to the total number of listed companies on both markets. The expert review panel was composed of professionals invited by the Securities Times, with a luxurious and professional lineup. They are (in no particular order):
Over the past three decades, the number of A-share listed companies has rapidly expanded, with the total number of listed companies in Shanghai and Shenzhen exceeding 4,000, basically covering the leading enterprises in various industries across the country. The quality of excellent companies is continuously improving, and the number of companies with a market capitalization of over 100 billion yuan is also steadily increasing. At the same time, these A-share companies have flourished across the country, revitalizing local economies and driving local industries. More and more listed companies have become economic pillars and lifelines for their localities, playing an important role in local industrial development and employment.
Health Yuan, which was selected for the "Capital Market 30th Anniversary Regional Economic Leader" honor roll, has always regarded scientific and technological innovation as one of the driving forces for its development. Since its listing, under the leadership of Chairman Zhu Baoguo, Health Yuan has continuously invested in scientific and technological innovation. To build a leading brand in respiratory inhalation preparations, Health Yuan has invested over 100 million yuan in R&D in recent years, collaborating with top domestic R&D teams to conduct in-depth research on respiratory medications. Years of R&D accumulation have yielded fruitful results for Health Yuan. Announcements show that Health Yuan currently has several products successfully launched in the respiratory field. Last year, two varieties of levalbuterol and combined ipratropium bromide inhalation preparations were approved, and this year, two varieties of single ipratropium bromide and budesonide suspension were approved, initially building a domestic inhalation preparation product matrix that breaks the monopoly of foreign companies.
At the new historical starting point of China's economic development, Health Yuan will always remain true to its original aspiration, adhere to scientific research-driven development, and develop new drugs! We will continuously optimize and strengthen the path of sustainable development, promote the formation of more competitive major health products from patented achievements, and strive for the continuous revitalization of the national pharmaceutical industry!
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
Sorry,当前栏目暂无内容!
您可以查看其他栏目或返回 首页
Sorry,The current column has no content!
You can view other columns or return Home